Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 25, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Aug. 23, 2024 -- The prevalence of diabetes increased in the United States from 2012 to 2022, according to a research letter published online July 18 in Diabetes, Obesity and Metabolism.

Sulakshan Neupane, from the University of Georgia in Athens, and colleagues examined recent national trends and disparities in self-reported diabetes prevalence among U.S. adults. The analysis included 5.3 million participants in the Behavioral Risk Factor Surveillance System (2012 to 2022).

The researchers found that the overall prevalence of diabetes increased significantly by 18.6 percent during the study period, across all sociodemographic groups. The prevalence was highest among non-Hispanic Black people (15.8 percent) and individuals aged 65 years and older (23.86 percent). Compared with non-Hispanic White individuals, odds were higher among Hispanic individuals (adjusted odds ratio [aOR], 1.60), non-Hispanic Asians (aOR, 1.67), and non-Hispanic Black individuals (aOR, 2.10). Men had a slightly higher prevalence than women (12.56 versus 11.56 percent). Prevalence was 56 percent higher among individuals with lower incomes. Individuals with obesity faced the highest prevalence -- 19.23 percent -- compared with individuals with normal weight.

"This study showed significant increases in diabetes prevalence across the United States from 2012 to 2022, aligning with previous research demonstrating rising trends nationally over recent decades," the authors write. "Persistently high and increasing prevalence underscores the alarming diabetes epidemic facing the United States."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-26 13:54

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords